| Literature DB >> 29983765 |
Azhar Jan Battoo1, Altaf Gauhar Haji1, Zahoor Ahmad Sheikh1, Krishnakumar Thankappan2, Wahid Abdul Mir1.
Abstract
Introduction There is difference of opinion about the placement of the drain in thyroid surgeries, and, to the best of our knowledge, the efficacy of drainless total thyroidectomy regarding various parameters of thyroid lesions has not been well-established. Objective To report our experience with drainless total thyroidectomy, and to define an appropriate patient population for its performance. Methods This is a retrospective case analysis of the patients who underwent total thyroidectomy for intrathyroidal lesions with or without central neck dissection in a tertiary referral hospital (number = 74). The patients, who had undergone total thyroidectomy without any drain insertion, were analyzed, and the relationships among various parameters of thyroid lesions were noted in relation to seroma and hematoma formation. Results Seroma formation was noted only in 5 out of 74 patents (6.75%). All of the seromas that occurred were observed in patients with thyroid lesions < 4 cm, and 4 out of 5 seromas were observed in patients with a malignant pathology. There was no statistically significant difference in seroma formation between patients younger or older than 50 years of age. The nature of the lesion, whether benign or malignant, did not affect the formation of seroma. Of interest is the fact that none of the 10 patients who had central neck dissection performed as part of their treatment developed seroma. Conclusions Drainless total thyroidectomy is safe across all age groups for patients harboring either benign or malignant thyroid pathologies. However, caution is to be observed in opting for drainless total thyroidectomy in patients with large lesions (> 5 cm).Entities:
Keywords: intrathyroidal lesions; seroma; total thyroidectomy
Year: 2017 PMID: 29983765 PMCID: PMC6033605 DOI: 10.1055/s-0037-1606183
Source DB: PubMed Journal: Int Arch Otorhinolaryngol ISSN: 1809-4864
Demographic, epidemiologic, and clinical data of the cases of intrathyroidal lesions
| Variable | Number (%) |
|---|---|
|
| |
| ≤ 50 years | 56 |
| > 50 years | 18 |
|
| |
| Female | 62 |
| Male | 12 |
|
| |
| Bethesda III | 03 |
| Bethesda IV | 25 |
| Bethesda VI | 41 |
| Medullary thyroid carcinoma | 03 |
|
| |
| ≤ 4 cm | 64 |
| > 4 cm | 10 |
|
| |
| T1 | 13 |
| T2 | 32 |
| T3 | 08 |
|
| |
| Central neck dissection performed*** | 10 |
| Central neck dissection not performed | 64 |
|
| |
| Present | 28 |
| Absent | 25 |
|
| |
| Present | 28 |
| Absent | 25 |
|
| |
| Papillary thyroid carcinoma | 44 |
| Follicular thyroid carcinoma | 06 |
| Medullary thyroid carcinoma | 03 |
| Follicular Neoplasm | 16 |
| Colloid Goiter | 04 |
| Hashimoto Thyroiditis | 01 |
|
| |
| Seroma formation | 05 |
| Hematoma formation | 01 |
| Permanent recurrent laryngeal nerve palsy**** | 01 |
| Transient recurrent laryngeal nerve palsy | 03 |
| Permanent hypocalcemia | 00 |
| Transient hypocalcemia | 04 |
Notes: *Two cases had iliac and sacral metastasis, and were diagnosed as having follicular carcinoma; **for malignant lesions only; ***three central neck dissections were bilateral; ****in this case, the patient had a nerve going through the tumor; since he underwent a preoperative fine needle aspiration cytology of Bethesda IV and malignancy could not be ruled out, sacrificing the nerve was deemed justifiable.
Relationship of various epidemiologic and clinicopathological variables with seroma formation in patients with intrathyroidal lesions
| Variable | Seroma present | Seroma absent |
|
|---|---|---|---|
|
| 0.35 | ||
|
≤ 50 years (
| 03 | 53 | |
|
> 50 years (
| 02 | 16 | |
|
| 0.18 | ||
|
Female (
| 03 | 59 | |
|
Male (
| 02 | 10 | |
|
| 0.60 | ||
| ≤ 4 cm | 05 | 59 | |
| > 4 cm | 00 | 10 | |
|
| 1.00 | ||
| Malignant | 04 | 49 | |
| Benign | 01 | 20 | |
|
| 0.57 | ||
| T1 + T2 | 04 | 39 | |
| T3 | 00 | 10 | |
|
| 0.57 | ||
| Central neck dissection performed* | 00 | 10 | |
| Central neck dissection not performed | 04 | 39 | |
|
| 0.33 | ||
| Present | |||
| Absent | 03 | 53 | |
|
| 0.33 | ||
| Present | |||
| Absent | |||
Note: *Since these parameters are features of malignancy, for them, only the malignant cases were considered.